NCT01820156

Brief Summary

Study Objectives: Obstructive sleep apnea (OSA) diagnosis using simplified methods such as home respiratory polygraphy (HRP) is only recommended in patients with a high pre-test probability. The aim is to determine the diagnostic efficacy, therapeutic decision-making and costs of OSA diagnosis using PSG or three consecutive studies of HRP in patients with mild-moderate suspicion of sleep apnea or with co-morbidity that can mask OSA symptoms. Design and Setting: Randomized, blinded, crossover study of three nights of HRP (3N-HRP) vs. PSG. The diagnostic efficacy was evaluated with ROC curves. Therapeutic decisions to assess concordance between the two different approaches were analyzed by sleep physicians and respiratory physicians (staff and residents) using agreement level and kappa coefficient. The costs of each diagnostic strategy were considered.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2012

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2012

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 20, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 28, 2013

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2013

Completed
Last Updated

March 24, 2015

Status Verified

September 1, 2013

Enrollment Period

8 months

First QC Date

March 20, 2013

Last Update Submit

March 23, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Therapeutic decision based on full PSG or respiratory polygraphy data (3 nights)

    The investigators want to compare the clinical decision between full PSG (CPAP or NO CPAP)and respiratory polygraphy performed during 3 nights (CPAP or NO CPAP) when there is discrepancy between symptoms and data from respiratory polygraphy.

    Three months

Secondary Outcomes (2)

  • Apnea and Hypopnea Index (AHI)

    3 months

  • Cost-effectiveness analysis

    3 months

Study Arms (2)

HRP-PSG

EXPERIMENTAL

First performance three nights of HRP and following one night of laboratory PSG

Device: Home Respiratory PolygraphyDevice: Standard Polysomnography

PSG-HRP

EXPERIMENTAL

First perform laboratory PSG and following three nights of HRP

Device: Home Respiratory PolygraphyDevice: Standard Polysomnography

Interventions

HRP-PSGPSG-HRP
HRP-PSGPSG-HRP

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with low or medium suspicion of Sleep Apnea
  • Patients with notorious comorbidity
  • Age between 18 and 75 years
  • Capability to fill in written questionnaires

You may not qualify if:

  • Patients with high suspicion of sleep apnea
  • Serious heart disease, resistant systemic hypertension, Suspicion of non-apneic sleep disorders, such as narcolepsy, REM behavior disorders and restless leg syndrome.
  • Patients with diagnosis of SAHS
  • Lack of informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Clinic

Barcelona, Barcelona, 08036, Spain

Location

Related Publications (1)

  • Guerrero A, Embid C, Isetta V, Farre R, Duran-Cantolla J, Parra O, Barbe F, Montserrat JM, Masa JF. Management of sleep apnea without high pretest probability or with comorbidities by three nights of portable sleep monitoring. Sleep. 2014 Aug 1;37(8):1363-73. doi: 10.5665/sleep.3932.

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD PhD. Pulmonary

Study Record Dates

First Submitted

March 20, 2013

First Posted

March 28, 2013

Study Start

February 1, 2012

Primary Completion

October 1, 2012

Study Completion

June 1, 2013

Last Updated

March 24, 2015

Record last verified: 2013-09

Locations